Post traumatic stress disorder among patients who survived COVID 19

Introduction Research on past coronavirus outbreaks, including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), indicates a high likelihood of symptoms and psychiatric disorders in survivors, including symptoms of stress. post-traumatic stress disorder (PTSD) and post-traumatic stress disorder (PTSD) Objectives This study therefore set out to highlight the impact of COVID-19 infection on mental health by screening them for posttraumatic stress Methods It is a retrospective study that includes patients who were tested positive with COVID 19 (RT PCR using a nasopharyngeal test ) and who have seeked medical care at emergencies during a month . The post traumatic stress score disorder: PCL-5 was calculated on day 30 and day 90. The evolution of the patients health state (Recovery or deterioration) was marked. All data were analyzed by SPSS. Results we included during the study period 200 patients complying with the inclusion criteria. Post traumatic stress was diagnosed in 146 patients (73% of patients). Post-traumatic stress was diagnosed in rather elderly patients; the average age was 51.8 years with a female predominance (57.5%). 63.6% of patients with PTSD had a cough; 35.7% had dyspnea; 49.7% were febrile, 43.9% had arthromyalgia, 15% had anosmia.The disappearance of the signs was after 8.3 days on average, it lasted longer (14.6 days) in the patient who developed PTSD.In this series, 47.3% of patients diagnosed with PTS infected their relatives Conclusions This study contributes to a better understanding of the factors that determine the impact of traumatic events such as a pandemic on people’s mental health.Post traumatic stress disorder is so common among COVID 19 patients and it has a huge influence on the evolution of their health state . This is why all health workers have to fight against COVID and its effects on both physical and mental health . Highlighting the fact that a psychological assistance is highly recommended in the management ofCOVID19 patients in order to improve their prognosis Disclosure of Interest None Declared